Blueberry begins a collaboration with the University of Manchester

Blueberry begins a collaboration with the University of Manchester exploring the mode of action and therapeutic potential of novel antiflammatory agents. 

Blueberry Therapeutics (Blueberry) today announced that it had started a collaboration with Professor Ian Kimber and Dr. Rebecca Dearman at the University of Manchester  to research the potential of novel antiflammatory agents. This project will explore the feasibility of these approaches for the treatment of a range of skin disorders including atopic dermatitis, psoriasis and acne. The collaboration is supported through a BBSRC Sparking Impact award made to the University of Manchester.

2015-03-20T10:36:40+00:00 May 15th, 2014|